Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II exploratory study of weekly topotecan in persistent or recurrent cervical cancer after platinum failure
2005-002495-15Phase 2Active
- Sponsor
- Grupo Español de Investigación en Cáncer de Ovario
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of topotecan in Cervical Cancer (CC), sponsored by Grupo Español de Investigación en Cáncer de Ovario. Primary endpoint: Objective response rate. Started Jul 2005; status: active.
02
Drugs
topotecan
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on 2005-002495-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002495-15.